ANI Pharmaceuticals, Inc. (ANIP)
74.24
-1.12
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
74.24
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Total Assets (Quarterly) : 1.494B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.494B |
| March 31, 2026 | 1.422B |
| December 31, 2025 | 1.440B |
| September 30, 2025 | 1.408B |
| June 30, 2025 | 1.343B |
| March 31, 2025 | 1.292B |
| December 31, 2024 | 1.284B |
| September 30, 2024 | 1.287B |
| June 30, 2024 | 920.75M |
| March 31, 2024 | 914.52M |
| December 31, 2023 | 904.42M |
| September 30, 2023 | 889.91M |
| June 30, 2023 | 859.34M |
| March 31, 2023 | 765.22M |
| December 31, 2022 | 770.16M |
| September 30, 2022 | 739.11M |
| June 30, 2022 | 751.33M |
| March 31, 2022 | 744.85M |
| December 31, 2021 | 781.09M |
| September 30, 2021 | 470.45M |
| June 30, 2021 | 480.16M |
| March 31, 2021 | 463.84M |
| December 31, 2020 | 468.78M |
| September 30, 2020 | 462.58M |
| June 30, 2020 | 465.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 482.23M |
| December 31, 2019 | 463.84M |
| September 30, 2019 | 456.78M |
| June 30, 2019 | 446.91M |
| March 31, 2019 | 434.39M |
| December 31, 2018 | 430.60M |
| September 30, 2018 | 439.44M |
| June 30, 2018 | 424.18M |
| March 31, 2018 | 418.02M |
| December 31, 2017 | 412.14M |
| September 30, 2017 | 370.47M |
| June 30, 2017 | 359.22M |
| March 31, 2017 | 357.14M |
| December 31, 2016 | 322.86M |
| September 30, 2016 | 319.38M |
| June 30, 2016 | 308.00M |
| March 31, 2016 | 291.59M |
| December 31, 2015 | 285.26M |
| September 30, 2015 | 283.28M |
| June 30, 2015 | 270.12M |
| March 31, 2015 | 265.98M |
| December 31, 2014 | 263.71M |
| September 30, 2014 | 107.64M |
| June 30, 2014 | 95.42M |
| March 31, 2014 | 96.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Viatris, Inc. | 35.04B |
| Liquidia Corp. | 521.92M |
| Elanco Animal Health, Inc. | 13.56B |
| Harmony Biosciences Holdings, Inc. | 1.373B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 896.90M |
| Shareholders Equity (Quarterly) | 597.21M |
| Debt to Equity Ratio | 1.022 |
| Current Ratio | 2.909 |
| Net Debt Paydown Yield | 0.39% |